Alcon AG ALC

TORONTO, September 28, 2026--Alcon, the global leader in eye care, announces the launch of Systane® PRO Preservative-Free (PF) in Canada.

Alcon has seen its share price grind lower in recent years, which naturally puts a spotlight on whether the current valuation still lines up with what the business earns. For anyone tracking the stock, the core question is whether the recent price level reflects a fair read of Alcon's earnings power. The share price has declined 26.8% over the past 5 years, which puts real pressure on the idea that the current market value is in step with the earnings the company produces. The business model...

Investing.com -- European medtech has had another bruising year, with only Demant and Sonova outperforming the Stoxx 600 in 2026 as the sector’s once-premium valuation continues to de-rate.

Vancouver, British Columbia--(Newsfile Corp. - September 21, 2026) - Platauro Metals Corp. (TSXV: PURO) (OTCQB: MEXGF) ("Platauro" or the "Company") announces that further to its news release of September 2, 2026, it has received TSX Venture Exchange ("TSXV") acceptance of the amendment to the option agreement between the Company's wholly-owned s subsidiary, Alcon Silver Corp. ("Alcon"), and Western Property Holdings, LLC (the "Optionor"), relating to Alcon's sole and exclusive right and option.

David Bailey has rejoined STAAR after participating in the successful campaign to block Alcon’s takeover of the company.

Ackman sees a hidden AI advantage in the latest addition to Pershing Square’s portfolio.

Cooper Cos. stock has fallen about 25% since Barron’s recommended it, but a low valuation, aggressive share buybacks, and takeover potential bolster the bull case.

UBS has recruited a trio of financial advisor teams managing around $2.65 billion in client assets. The teams joined UBS on Friday, according to registration records. The Mason Cisney Alcon Wealth Management Group, based in Pueblo, Colo., managed $1.4 billion at Morgan Stanley and produced annual revenue of more than $3.5 million.

Alcon's acquisitions, partnerships and new product launches support growth, but tariffs and intense competition remain key risks.

GENEVA, September 03, 2026--Alcon Launches UNITY® M, a Premium Ophthalmic Microscope Delivering Precise Control

Investors need to pay close attention to ALC stock based on the movements in the options market lately.

Alcon stock reacts to US Medicaid drug pricing agreement New US Medicaid drug pricing agreements involving Alcon (SWX:ALC) and eight other healthcare companies have put the stock in focus for investors assessing potential implications for its eye care drug portfolio. At around CHF58.30 per share, Alcon has seen short term share price pressure related to the Medicaid headlines, with the 1-day share price return down 0.44% and the year-to-date share price return down 8.25%. In contrast, the...

Focused on Medicaid, the new pacts now involve more than just large pharmaceutical companies, but still aren’t expected to meaningfully impact drugmaker profits.

These deals will require the companies to provide MFN prices to state Medicaid programmes nationally.

Trump expanded his drug pricing deal to 26 pharma firms as UBS says healthcare stocks still have room to climb.

GENEVA, August 26, 2026--Alcon Prices EUR 500 Million Senior Notes Offering

Sustainable Growth Advisers (SGA), an investment management company, released its second-quarter 2026 investor letter for its “Global Growth Strategy.” The letter can be downloaded here. The SGA Global Growth Portfolio returned 7.4% gross and 7.2% net, compared with 14.9% for the MSCI ACWI and 19.8% for the MSCI ACWI Growth Index. Momentum leadership and enthusiasm around […]